Stocks Hitting 52-Week Lows

Sunesis Pharmaceuticals

shares tumbled 69.88% to reach a new 52-week low of $2.00 as pivotal Phase 3 VALOR trial of acute myeloid leukemia treatment did not meet primary endpoint. EZchip Semiconductor

shares touched a new 52-week low of $21.90 after the company lowered its Q3 sales forecast. Alcobra

shares dropped 47.26% to reach a new 52-week low of $7.44 following the announcement of topline results from Phase III study of MDX in adult ADHD. Ciena

shares touched a new 52-week low of $16.205. Ciena shares have dropped 39.47% over the past 52 weeks, while the S&P 500 index has gained 16.41% in the same period.